BRPI0409861A - células- tronco hematopoiéticas e sua utilização em métodos de tratamento de doenças oculares neovasculares - Google Patents

células- tronco hematopoiéticas e sua utilização em métodos de tratamento de doenças oculares neovasculares

Info

Publication number
BRPI0409861A
BRPI0409861A BRPI0409861-7A BRPI0409861A BRPI0409861A BR PI0409861 A BRPI0409861 A BR PI0409861A BR PI0409861 A BRPI0409861 A BR PI0409861A BR PI0409861 A BRPI0409861 A BR PI0409861A
Authority
BR
Brazil
Prior art keywords
hscs
lin
isolated
methods
monocytes
Prior art date
Application number
BRPI0409861-7A
Other languages
English (en)
Inventor
Martin Friedlander
Atsushi Otani
Karen Dassilva
Stacey Hanekamp
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/628,783 external-priority patent/US7153501B2/en
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of BRPI0409861A publication Critical patent/BRPI0409861A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C12N5/0692—Stem cells; Progenitor cells; Precursor cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"CéLULAS-TRONCO HEMATOPOIéTICAS E SUA UTILIZAçãO EM MéTODOS DE TRATAMENTO DE DOENçAS OCULARES NEOVASCULARES". População de células-tronco hematopoiéticas, negativa para linhagem, derivada de medula óssea de mamífero adulto, isolada (Lin¬ -¬HSCs) que contém células progenitoras endoteliais (EPCs) capazes de recuperar vasos sangüineos retinianos e redes neuronais no olho. Preferivelmente pelo menos cerca de 20% das células em Lin¬ -¬HSCs isoladas expressam o antígeno de superfície celular CD31. As populações isoladas de Lin¬ -¬HSCs são úteis para o tratamento de doenças vasculares oculares. Em uma modalidade preferida, as Lin¬ -¬HSCs são isoladas por extração da medula óssea de um mamífero adulto; separação de vários monócitos da medula óssea; rotulagem dos monócitos com painel de anticorpos de linhagem conjugados a biotina a um ou mais antígenos de superfície de linhagem; remoção de monócitos que são positivos para os antígenos de superfície de linhagem a partir de vários monócitos, e recuperação de uma população de Lin¬ -¬HSCs contendo EPCs. Lin¬ -¬HSCs isoladas que foram transfectadas com genes terapeuticamente úteis também são fornecidas, e são úteis para liberação de genes ao olho para terapia genética baseada em células. Métodos de preparação de populações isoladas de células-tronco da invenção, e métodos de tratamento de doenças e danos oculares também são descritos.
BRPI0409861-7A 2003-05-02 2004-04-28 células- tronco hematopoiéticas e sua utilização em métodos de tratamento de doenças oculares neovasculares BRPI0409861A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46705103P 2003-05-02 2003-05-02
US10/628,783 US7153501B2 (en) 2002-07-25 2003-07-25 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
PCT/US2004/012989 WO2004098499A2 (en) 2002-07-25 2004-04-28 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith

Publications (1)

Publication Number Publication Date
BRPI0409861A true BRPI0409861A (pt) 2006-05-16

Family

ID=36908146

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0409861-7A BRPI0409861A (pt) 2003-05-02 2004-04-28 células- tronco hematopoiéticas e sua utilização em métodos de tratamento de doenças oculares neovasculares

Country Status (10)

Country Link
EP (2) EP1624758A4 (pt)
JP (2) JP4714682B2 (pt)
KR (3) KR101169261B1 (pt)
CN (2) CN1831119B (pt)
AU (2) AU2004237749B2 (pt)
BR (1) BRPI0409861A (pt)
CA (2) CA2526670C (pt)
MX (2) MXPA05011752A (pt)
RU (2) RU2345780C2 (pt)
ZA (2) ZA200509752B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2554662A1 (en) * 2011-08-05 2013-02-06 M Maria Pia Cosma Methods of treatment of retinal degeneration diseases
WO2013063383A2 (en) 2011-10-27 2013-05-02 Wellstat Ophthalmics Corporation Vectors encoding rod-derived cone viability factor
RU2495650C1 (ru) * 2012-02-29 2013-10-20 Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения и социального развития Российской Федерации Трехкомпонентный комплекс для клеточной терапии в офтальмологии
RU2485922C1 (ru) * 2012-03-28 2013-06-27 Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения и социального развития Российской Федерации Способ лечения "сухой" формы возрастной макулярной дегенерации
CN107043699B (zh) * 2017-04-25 2023-04-07 徐子雁 一种低能量激光诱导间充质干细胞血管化的试剂盒

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002224383A1 (en) * 2000-10-18 2002-04-29 Coriell Institute For Medical Research Method and marker for the isolation of human multipotent hematopoietic stem cells
ES2376866T3 (es) * 2002-07-25 2012-03-20 The Scripps Research Institute Células troncales hemotopoyéticas y procedimientos de tratamiento de las enfermedades oculares noeovasculares con las mismas

Also Published As

Publication number Publication date
AU2004237749A1 (en) 2004-11-18
AU2005239702A1 (en) 2005-12-22
ZA200509756B (en) 2006-10-25
MXPA05011752A (es) 2006-06-06
JP4714682B2 (ja) 2011-06-29
CN1831119B (zh) 2010-05-26
CA2526670A1 (en) 2004-11-18
JP2006166918A (ja) 2006-06-29
KR20060056420A (ko) 2006-05-24
CA2524063C (en) 2015-02-17
EP1624758A4 (en) 2007-03-07
CA2524063A1 (en) 2004-11-18
CA2526670C (en) 2011-06-14
CN1816281A (zh) 2006-08-09
AU2005239702B2 (en) 2010-03-04
EP1624758A2 (en) 2006-02-15
RU2345780C2 (ru) 2009-02-10
MXPA05011750A (es) 2006-06-06
EP1754783A1 (en) 2007-02-21
KR20060008968A (ko) 2006-01-27
CN100439493C (zh) 2008-12-03
JP2006525806A (ja) 2006-11-16
KR101224375B1 (ko) 2013-01-21
JP4714580B2 (ja) 2011-06-29
KR101169261B1 (ko) 2012-08-03
KR20120034251A (ko) 2012-04-10
CN1831119A (zh) 2006-09-13
ZA200509752B (en) 2006-11-29
RU2006103574A (ru) 2007-08-20
AU2004237749B2 (en) 2011-09-15
RU2389497C2 (ru) 2010-05-20
RU2005137569A (ru) 2006-06-10

Similar Documents

Publication Publication Date Title
Alatyyat et al. Umbilical cord stem cells: Background, processing and applications
WO2004098499A3 (en) Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
RU2562154C2 (ru) Амниотические адгезивные клетки
JP6180456B2 (ja) 分娩後の哺乳動物の胎盤、その使用およびそれに由来する胎盤幹細胞
Drela et al. Enhanced neuro-therapeutic potential of Wharton's Jelly–derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture
JP2014507389A (ja) 羊膜由来接着細胞を使用する脊髄損傷及び外傷性脳損傷の治療
KR20170116219A (ko) 조직 복구 및 재생을 위한 세포 증식 방법 및 약제학적 제제
US8900573B2 (en) Immune privileged and modulatory progenitor cells
Li et al. Optimized Langendorff perfusion system for cardiomyocyte isolation in adult mouse heart
EP1915440A2 (en) Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof
Sedov et al. Fetomaternal microchimerism in tissue repair and tumor development
Charron et al. Immunogenicity and allogenicity: a challenge of stem cell therapy
RU2007135220A (ru) Способ лечения ретинопатии при недоношенности и родственных ретинопатических заболеваний
BRPI0409861A (pt) células- tronco hematopoiéticas e sua utilização em métodos de tratamento de doenças oculares neovasculares
Spohn et al. More human BM-MSC with similar subpopulation composition and functional characteristics can be produced with a GMP-compatible fabric filter system compared to density gradient technique
BR9815440A (pt) Células intestinais parasitas viáveis isoladas
DE69734555D1 (de) Unsterbliche retinalzellinien und deren anwendungen
AU2017287529B2 (en) Prophylactic or therapeutic agent for organ fibrosis
Kurtzberg Umbilical cord blood: a novel alternative source of hematopoietic stem cells for bone marrow transplantation
WO2006031467A3 (en) Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
AU693441B2 (en) Blood-borne mesenchymal cells
CN118076364B (zh) Cd90+人羊膜上皮细胞在治疗移植物抗宿主病中的用途
RU2791738C1 (ru) Способ получения аутологичных регуляторных Т-лимфоцитов путем культивирования ex vivo в присутствии хорионического гонадотропина
US20250281541A1 (en) Composition for wound treatment comprising stem cell-derived extracellular vesicles with enhanced efficacy
Sauvageau et al. 1023–THE IMPORTANCE OF STEM CELL EXPANSION IN TOMORROW'S MEDICINE

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A01N 63/00 , A01N 65/00 , C12N 5/08

Ipc: C12N 5/074 (2010.01), A61K 35/28 (2006.01), A61P 2

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]